Phase 2 and 3 clinical study of the effect of Lamotrigine on cognition in patients with NF1

In this study, designed and conducted by ENCORE, the effect of the drug Lamotrigine on cognition was tested in NF1 patients. A total of 41 participants took part in the study. The study has been completed and the results are expected by the end of 2020.